Android app Apple app link

Merck & Co., Inc. (MRK)'s Blockbuster Drugs: A Key Player in Ken Griffin's Portfolio

By Yahoo! Finance   |   1 month ago
Merck & Co., Inc. (MRK)'s Blockbuster Drugs: A Key Player in Ken Griffin's Portfolio

We recently featured Ken Griffin's stock portfolio, highlighting Merck & Co., Inc. against other stocks. Griffin's success with Citadel Investment Group, boasting a $518 billion portfolio, includes Citadel Securities' $22 billion value.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.